TCI’s Natural GLP-1 Metabolic Breakthrough Featured in NutraIngredients Spotlight
As global demand for GLP-1-based weight management solutions skyrockets, the health and wellness industry is shifting toward what experts call the "Endogenous Revolution"—moving beyond pharmaceutical drug injections to natural, food-grade triggers that stimulate the body's own satiety pathways. TCI's featured formulation represents a major leap forward in non-pharmacological metabolic solutions.
TCI's sponsored feature on NutraIngredients, titled "Beyond GLP-1 drugs: How dietary ingredients can naturally support body's own satiety hormone," introduces TCI's clinical data and its approach to natural appetite regulation and post-meal metabolic support.

How to formulate metabolic support with robust clinical evidence
- GLP-1 Elevation: In a randomized, controlled cross-over trial with 25 adults, participants using the formulation showed a 16% increase in baseline, pre-meal GLP-1 levels.
- Post-Meal Glycemic Support: Following a glucose challenge, active GLP-1 levels in the formulation group increased approximately 3.8- to 4.7-fold.
- Real-World Results: In an open-label consumer study of 560 participants (minimum 14 days of use; body weight self-reported), participants achieved an average weight reduction of 4.9 kg (approx. 10.8 lbs).
Sources: Journal of Obesity and Weight Loss Therapy, 2026; 16:878; Acta Scientific Medical Sciences, 2024; 8(10): 62-67.
Read the full feature
Stay informed on the future of metabolic health. Click the link below to read the full article on NutraIngredients (sponsored content):
👉 Read — Beyond GLP-1 drugs: How dietary ingredients can naturally support body's own satiety hormone